INTU
50
5
UAL
77
3
CAH
50
2
FITB
45
7
CRM
59
4
SWKS
48
2
LOW
46
4
SYK
50
2
KEY
36
5
TROW
45
8
GWW
53
7
AME
48
3
EXPE
77
2
EL
31
-2
STI
3
2
L
49
4
AIG
38
6
CI
38
3
PLD
41
6
AEE
64
3
INTU
50
5
UAL
77
3
CAH
50
2
FITB
45
7
CRM
59
4
SWKS
48
2
LOW
46
4
SYK
50
2
KEY
36
5
TROW
45
8
GWW
53
7
AME
48
3
EXPE
77
2
EL
31
-2
STI
3
2
L
49
4
AIG
38
6
CI
38
3
PLD
41
6
AEE
64
3
Financhill
Back

Viking Therapeutics Stock Predictions

Free Stock Analysis: See What Your Stock is Really Worth

Analyze Any Stock Free
Sell
8

VKTX
Viking Therapeutics

Last Price:
$34.01
Seasonality Move:
30.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free

Viking Therapeutics Stock Forecast

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 66% based on the past 9 years of stock performance.
  • Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Viking Therapeutics Stock Undervalued?
    The current Viking Therapeutics [VKTX] share price is $33.93. The Score for VKTX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 66% based on the past 9 years of stock performance.

Viking Therapeutics Stock Rating

Sell
8
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics overpriced?

  • Viking Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com

52-Week Data

52-Week High:
99.41
52-Week Low:
20.28

Prediction Charts

Market Cap:
3.8B
Price in USD:
33.93
Volume:
7.7M
Beta:
1.27

Technical Analysis

SMA50:
50.18
SMA100:
57.17
SMA200:
59.78
52-Wk Change:
58.26%

Stock Predictions

  • Is Viking Therapeutics stock public?
    Yes, Viking Therapeutics is a publicly traded company.
  • What is the Viking Therapeutics stock quote today?
    The Viking Therapeutics stock price is 33.93 USD today.
  • How to buy Viking Therapeutics stock online?
    You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-23 42.30 42.32 42.67 40.77
Dec-24 42.32 42.35 42.91 41.61
Dec-26 41.94 42.68 43.48 41.52
Dec-27 42.17 41.16 42.82 40.80
Dec-30 40.06 39.77 40.69 39.33
Dec-31 40.24 40.24 40.48 39.09
Jan-2 40.74 41.12 42.27 40.50
Jan-3 41.14 42.89 42.95 41.14
Jan-6 43.28 42.53 43.55 42.17
Jan-7 42.50 41.66 43.00 40.68
Jan-8 41.52 40.60 41.60 40.31
Jan-10 40.00 39.31 40.16 38.35
Jan-13 38.25 38.88 39.40 36.77
Jan-14 38.45 33.93 38.46 33.35

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.30 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.